Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function ; volume:19 ; number:1 ; day:17 ; month:7 ; year:2020 ; pages:1-7 ; date:12.2020
Malaria journal ; 19, Heft 1 (17.7.2020), 1-7, 12.2020
- Urheber
-
Martin Ramírez, Alexandra
Lombardia González, Carlos
Soler Maniega, Tamara
Gutierrez Liarte, Ángela
Domingo García, Diego
Lanza Suárez, Marta
Bernal Fernández, María Josefa
Rubio, José Miguel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-020-03326-1
- URN
-
urn:nbn:de:101:1-2020092221543369763903
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin Ramírez, Alexandra
- Lombardia González, Carlos
- Soler Maniega, Tamara
- Gutierrez Liarte, Ángela
- Domingo García, Diego
- Lanza Suárez, Marta
- Bernal Fernández, María Josefa
- Rubio, José Miguel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Genetic variability of Plasmodium vivax from primary–relapses paired samples
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Primaquine in vivax malaria: an update and review on management issues
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Genetic variability of Plasmodium vivax from primary–relapses paired samples
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Primaquine in vivax malaria: an update and review on management issues
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases
Natural relapses in vivax malaria induced by Anopheles mosquitoes
Genetic variability of Plasmodium vivax from primary–relapses paired samples
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
Primaquine in vivax malaria: an update and review on management issues
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
Primaquine radical cure of Plasmodium vivax: a critical review of the literature
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure